Composition

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine. Each single dose (0.5 mL) is formulated to contain: Active Ingredients: 4 mcg each of meningococcal A, C, Y and W-135 polysaccharides conjugated to a total of approximately 48 ?g of a diphtheria toxoid protein carrier, Sodium Chloride 4.25 mg, Sodium Phosphate, Dibasic, Anhydrous QS phosphate 10 mM, Sodium Phosphate, Monobasic QS phosphate 10 mM Other Ingredients: Water for Injection QS 0.5 mL Menactra® is preservative-free. No adjuvant is added. Description: Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] is a sterile, clear to slightly turbid liquid containing Neisseria meningitidis serogroups A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid protein. The polysaccharides are covalently linked to diphtheria toxoid and purified by serial diafiltration. The four meningococcal components, present as individual serogroup-specific glycoconjugates, compose the final formulated vaccine  

ATC Code

J07AH08  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

0.5 mL x 1's (in single-dose vial)  

Product Description

Solution for injection. Menactra® is a clear to slightly turbid liquid

Manufacturer Name

Sanofi Pasteur S.A.

Manufacturer Country

FRANCE  

Approval Date

2022-02-22  

Expiry Date

2026-12-15